IRB Study Number 22-510
Status Recruiting
Institute Neurological Institute
Description
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.
Inclusion Criteria
Sporadic or familial ALS diagnosed as clinically possible, probable, lab-supported probable, or definite ALS defined by revised El Escorial criteria (Appendix I).
Age 18 years or older.
Capable of providing informed consent and complying with study procedures, in the SI’s opinion.
Exclusion Criteria
Clinically significant unstable medical condition (other than ALS) that would pose a risk to the participant, according to SI’s judgment (e.g., cardiovascular instability, systemic infection, untreated thyroid dysfunction), or clinically significant laboratory abnormality or EKG changes.
